Advertisement

Trichomoniasis: under control or undercontrolled?

  • David Soper
    Correspondence
    Reprint requests: David Soper, MD, Department of Obstetrics and Gynecology, Medical University of South Carolina, 96 Jonathan Lucas St, Suite 634, Charleston, SC 29425.
    Affiliations
    Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC USA
    Search for articles by this author

      Abstract

      Aside from human papillomavirus, trichomoniasis is the most common sexually transmitted infection in the United States today, yet it has long been regarded as a sexually transmitted infection of minor importance. Medical opinion has traditionally held that it plays little role in health complications in women, and it is rarely seen in men. However, evidence has recently accumulated implicating Trichomonas vaginalis as a contributor to a variety of adverse outcomes among both sexes. Among both women and men, the association of T vaginalis with human immunodeficiency acquisition and transmission has been shown in multiple studies. Among women, trichomoniasis may play a role in development of cervical neoplasia, postoperative infections, and adverse pregnancy outcomes and as a factor in atypical pelvic inflammatory disease and infertility. Among men, trichomoniasis has emerged as a cause of nongonoccocal urethritis and as contributing to male factor infertility. As evidence continues to accumulate, the time has come to increase diagnostic efforts beyond traditional sexually transmitted disease clinic settings.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gerbase A.C
        • Rowley J.T
        • Heymann D.H.L
        • Berkley S.F.B
        • Piot P
        Global prevalence and incidence estimates of curable STD's.
        Sex Transm InfectSuppl. 1998; 74: 512-517
        • Cates W
        Estimates of the incidence and prevalence of sexually transmitted diseases in the United States.
        Sex Transm DisSuppl. 1999; 26: 52-57
        • Wendel K.A
        • Erbelding E.J
        • Gaydos C.A
        • Rompalo A.M
        Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for the detection and treatment of vaginal trichomoniasis.
        Clin Infect Dis. 2002; 35: 576-580
        • Hager D.W
        Trichomonas vaginalis infection.
        in: Pastorek J.C Obstetric and gynecologic infectious disease. Rowen Press, New York1994: 537-543
        • Mou S.M
        • Faro S
        Trichomonas vaginalis.
        in: Faro S Soper D.E Infectious diseases in women. WB Saunders, Philadelphia2001: 240-247
        • Petrin D
        • Delgaty K
        • Bhatt R
        • Garber G
        Clinical and microbiological aspects of Trichomonas vaginalis.
        Clin Microbiol Rev. 1998; 11: 300-317
        • Rein M
        • Muller M
        Trichomonas vaginalis and trichomiasis.
        in: Holmes K.K Sexually transmitted diseases. McGraw-Hill, New York1990: 481-492
        • Wölner-Hanssen P
        • Krieger J.N
        • Stevens C.E
        • et al.
        Clinical manifestations of vaginal trichomoniasis.
        JAMA. 1989; 261: 571
        • Kaydos C
        • Swygard H
        • Wise S
        • Sena A
        • Leone P
        • Miller W
        • et al.
        Development and validation of PCR based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women.
        J Clin Microbiol. 2002; 40: 89-95
        • Spence M.A
        • Hollander D.H
        • Smith J
        • et al.
        The clinical and laboratory diagnosis of Trichomonas vaginalis infection.
        Sex Transm Dis. 1980; 7: 168
        • Fouts A.C
        • Kraus S.J
        Trichomonas vaginalis: a reevaluation of its clinical presentation and laboratory diagnosis.
        J Infect Dis. 1980; 141: 137-143
        • Osborne N.G
        • Grubin L
        • Pratson L
        Vaginitis in sexually active women: relationship to nine sexually transmitted organisms.
        Am J Obstet Gynecol. 1982; 142: 962-967
        • Weisenfeld H
        • Lowry D
        • Heine P
        • Krohm M
        • Bittner H
        • Kellinger K
        • et al.
        Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis.
        Sex Transm Dis. 2001; 28: 321-325
        • Smith K
        • Harrington K
        • Wingwood G
        • Oh K
        • Hook E
        • Di Clemente R
        Self obtained vaginal swabs for diagnosis of treatable sexually transmitted diseases in adolescent girls.
        Arch Pediatr Adolesc Med. 2001; 155: 676-679
        • Cotch M.F
        • Pastorek II, J.G
        • Nugent R.P
        • Hillier S.L
        • Gibbs R.S
        • Martin D.H
        • et al.
        Trichomonas vaginalis associated with low birth weight and preterm delivery: the Vaginal Infections and Prematurity Study Group.
        Sex Transm Dis. 1997; 24: 353-360
        • Hardy P.H
        • Hardy J.B
        • Nell E.E
        • Graham D.A
        • Spence M.R
        • Rosenbaum R.C
        Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome.
        Lancet. 1984; 2: 333-337
        • Bachmann L
        • Lewis I
        • Allen R
        • Schwebke J
        • Leviton L
        • Siegal H
        • et al.
        Risk and prevalence of treatable sexually transmitted diseases at Birmingham substance abuse treatment facility.
        Am J Public Health. 2000; 155: 676-679
        • Shuter J
        • Bell D
        • Graham D
        • Holbrook K.A
        • Bellin E.Y
        Rates of risk factors for trichomoniasis among pregnant inmates in New York City.
        Sex Transm Dis. 1998; 25: 303-307
        • Cu-Uvin S
        • Hogan J.W
        • Warren D
        • Klein R.S
        • Peirpert J
        • Schuman P
        • et al.
        Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)–seropositive and high-risk HIV–seronegative women.
        Clin Infect Dis. 1999; 29: 1145-1150
        • Wilson T.E
        • Minkoff H
        • DeHovitz J
        • Feldman J
        • Landesman S
        The relationship of cocaine use and human immunodeficiency virus serostatus to incident sexually transmitted diseases among women.
        Sex Transm Dis. 1998; 25: 70-75
      1. Butler WJ, Spence MR, Brockman MT. Trichomoniasis: a male urethritis.

        • Ozbilgin A
        • Ozbel Y
        • Alka A
        • Guruz Y
        • Atambay M
        • Tasci S
        • et al.
        Trichomoniasis in a non-gonococcic urethitis among male patients.
        J Egypt Soc Parasitol. 1994; 24: 621-625
        • Krieger J.N
        Trichomoniasis in men: old issues and new data.
        Sex Transm Dis. 1995; 22: 83-96
        • Joyner J.L
        • Douglas Jr., J.M
        • Ragsdale S
        • Foster M
        • Judson F.N
        Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted disease clinic.
        Sex Transm Dis. 2000; 27: 236-240
        • Borchardt K.A
        • Al-Haraci S
        • Maida N
        Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test.
        Genitourin Med. 1995; 71: 236-240
        • Schwebke J.R
        • Cotton B
        • Venglarik M
        • Lawing L
        Detection of Trichomonas vaginalis in males: traditional vs molecular methods.
        ([abstract])Proceedings of the 41st annual Interscience Conference on Antimicrobials Agents and Chemotherapy; 2001 December 16-19; Chicago, Ill. The Conference, Chicago2001
        • Saxena S.B
        • Jenkens R.R
        Prevalence of Trichomonas vaginalis in men at high risk for sexually transmitted diseases.
        Sex Transm Dis. 1991; 18: 138-142
        • Weston T.E.T
        • Nicol C.S
        Natural history of trichomonal infection in males.
        Br J Venereal Dis. 1963; 39: 251-257
        • Bowden F.J
        • Garnett G
        Trichomonas vaginalis epidemiology: parameterising and analyzing a model of treatment interventions.
        Sex Transm Infect. 2000; 76: 248-256
        • Krieger J.N
        Consider diagnosis and treatment of trichomoniasis in men.
        Sex Transm Dis. 2000; 27: 241-242
        • Zhang Z
        • Begg C
        Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies.
        Int J Epidemiol. 1994; 23: 682-690
        • Viikki M
        • Pukkala E
        • Nieminen P
        • Hakama M
        Gynecological infections as risk determinants of subsequent cervical neoplasia.
        Acta Oncol. 2000; 39: 71-75
        • Minkoff H
        • Grunebaum A.N
        • Schwartz R.H
        • Feldman J
        • Cummings M
        • Crombleholme W
        • et al.
        Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy.
        Am J Obstet Gynecol. 1984; 150: 965-972
        • Sherman K.J
        • Daling J.R
        • Weiss N.S
        Sexually transmitted disease and tubal infertility.
        Sex Transm Dis. 1987; 14: 12-16
        • Sherman K
        • Chow W
        • Daling J
        • Weiss N
        Sexually transmitted diseases and the risk of tubal pregnancy.
        J Reprod Med. 1988; 33: 30-34
        • Grodstein F
        • Goldman M
        • Cramer D
        Relation of tubal infertility to history of sexually transmitted diseases.
        Am J Epidemiol. 1993; 137: 577-584
        • El-Shazly A.M
        • Al-Naggar H.M
        • Soliman M
        • El-Negeri M
        • El-Nemr H.E
        • Handousa A.E
        • et al.
        A study on trichomoniasis and female infertility.
        J Egypt Soc Parasitol. 2001; 31: 545-553
        • Soper D.E
        • Bump R.C
        • Hurt W.G
        Bacterial vaginosis and trichomonas vaginalis are risk factors for cuff cellulitis after abdominal hysterectomy.
        Am J Obstet Gynecol. 1990; 163: 1016-1021
        • Wang C
        • McClelland S
        • Reilly M
        • Overbaugh J
        • Emery S.L
        • Mandaliya K
        • et al.
        The effect of treatment of vaginal infections on shedding of HIV-type I.
        J Infect Dis. 2001; 183: 1017-1022
        • Sorvillo F
        • Kerndt P
        Trichomonas vaginalis and amplification of HIV-I transmission.
        Lancet. 1998; 351: 213-214
        • Laga M
        • Monoka A
        • Kivuvu M
        • Tuliza M
        • Nzila N
        • Goeman J
        • et al.
        Non-ulcerative sexually transmitted diseases as risk factors for HIV-I transmission in women: results from a cohort study.
        AIDS. 1993; 7: 95-102
        • Dallabetta G
        • Miotti P
        • Chiphangwi J
        • Saah A.J
        • Liomba G
        • Odaka N
        • et al.
        High socioeconomic status is a risk factor for HIV type I infection but not for sexually transmitted diseases in women in Maui: implications for HIV-I control.
        J Infect Dis. 1993; 167: 36-42
        • Moodley P
        • Wilkinson D
        • Connolly C
        • Moodley J
        • Sturm W
        Trichomonas vaginialis is associated with pelvic inflammatory disease in women infected with HIV.
        Clin Infect Dis. 2002; 34: 519-522
        • Sorvillo F
        • Smith C
        • Kerndt P
        • Ash L
        Trichomonas vaginalis, HIV, and African-Americans.
        Emerg Infect Dis. 2001; 7: 927-932
        • Yap E.H
        • Ho T.H
        • Chan Y.C
        • Thong T.W
        • Ng G.C
        • Ho L.C
        • et al.
        Serum antibodies to T vaginalis in invasive cervical cancer patients.
        Genitourin Med. 1995; 71: 402-404
        • Sayed S.A
        • el-Wakil H.S
        • Kamel W.M
        • Mahmoud M.S
        A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women.
        J Egypt Soc Parasitol. 2002; 32: 167-178
        • Paisarntantiwong R
        • Brockman S
        • Clarke L
        • Landesman S
        • Feldman J
        • Minkoff H
        The relationship of vaginal trichomoniasis and pelvic inflammatory disease among women colonized with Chlamydia trachomatis.
        Sex Transm Dis. 1995; 22: 344-347
        • Gardner W.A
        • Culberson D.E
        • Bennett B.D
        Trichomonas vaginalis in the prostate gland.
        Arch Pathol Lab Med. 1986; 110: 430-432
        • Hobbs M.M
        • Kzembe P
        • Reed A.W
        • Miller W.C
        • Nkata E
        • Zimba D
        • et al.
        Trichomonas vaginalis as a cause of urethritis in Malawian men.
        Sex Transm Dis. 1999; 26: 381-387
        • Krieger J.N
        • Alderete J.F
        Trichomonas vaginalis and trichomoniasis.
        in: Holmes K.K Sexually transmitted diseases. 3rd ed. McGraw-Hill Health Professions, New York1999: 587-604
        • Graves A
        • Garder W.A
        Pathogenicity of Trichomonas vaginalis.
        Clin Obstet Gyncecol. 1993; 36: 145-152
        • Martinez-Garcia F
        • Regardera J
        • Mayer R
        • Sanchez S
        • Nistal M
        Protozoan infections in the male genital tract.
        J Urol. 1996; 156 ([review]): 340-349
        • Gopalkrishnan K
        • Hinduja I
        • Kumar A
        Semen characteristics of asymptomatic males affected by Trichomonas vaginalis.
        J In Vitro Fertil Embryo Transfer. 1990; 7: 165-167
        • Jarecki-Black J
        • Lushbaugh W
        • Golosov L
        • Glassman A.B
        Trichomonas vaginalis: preliminary characterization of sperm motility inhibiting factor.
        Am Clin Lab Science. 1988; 18: 484-489
        • Tuttle J
        • Holbrook T
        • Derrick F
        Interference of human spermatozoal motility by Trichomonas vaginalis.
        J Urol. 1977; 118: 1024-1025
        • Skerk V
        • Schonwald S
        • Krhen I
        • Markovinovic L
        • Beus A
        • Kuzmanovic N.S
        • et al.
        Aetiology of chronic prostatitis.
        Int J Antimicrob Agents. 2002; 19: 471-474
        • Shappert S.M
        National ambulatory medical care survey, 1991 summary.
        Natl Vital Health Stat. 1994; : 13
        • Klebanoff M
        • Carey C
        • Hauth J
        • Hillier S
        • Nugent R.P
        • Thom E.A
        • et al.
        Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.
        N Engl J Med. 2001; 345: 487-493
        • Morgan I
        Metronidazole treatment in pregnancy.
        Int J Gynaecol Obstset. 1978; 15: 501-502
        • Keith L.G
        • Friberg J
        • Fullan N
        • Bailey R
        • Berger G.S
        The possible role of Trichomonas vaginalis as a “vector” for the spread of other pathogens.
        Int J Fertil. 1986; 31: 272-277
        • Heine P
        • McGregor J.A
        Trichomonas vaginalis: a reemerging pathogen.
        Clin Obstet Gynecol. 1993; 36: 137-144
        • Levine G
        Sexually transmitted parasitic diseases.
        Prim Care. 1991; 18: 101-128
        • Hillstrom L
        • Peterson L
        • Pulsson E
        • Sandstrom S
        Comparison of ornidazole and tinidazole in single dose treatment of trichomoniasis in women.
        Br J Venereal Dis. 1977; 53: 193-194
        • Hook E.W
        Trichomonas vaginalis—no longer a minor STD.
        Sex Transm Dis. 1999; 26: 388-389
        • Hager W.D
        • Brown S.T
        • Kraus S.J
        • Kleris G.S
        • Perkins G.J
        • Henderson M
        Metonidazole for vaginal trichomoniasis: seven day vs single dose regimen.
        JAMA. 1980; 244: 1219-1220
        • Underhill R.A
        • Peck J.E
        Causes of therapeutic failures after treatment of trichomonal vaginitis with metronidazole: comparison of single dose treatment with a standard regimen.
        Br J Clin Pract. 1974; 28: 134-136
        • Dykers J.R
        Single dose metronidazole for trichomonal vaginitis.
        N Engl J Med. 1975; 293: 23-24
        • Fleury F.S
        • Van Bergen W.S
        • Prentice R.L
        • Russell J.G
        • Singleton J.A
        • Standard J.V
        A single dose of two grams of metronidazole for Trichomonas vaginalis vaginitis.
        Am J Obstet Gynecol. 1977; 128: 320-322
        • Sobel J.D
        Vaginitis.
        N Engl J Med. 1997; 337: 1896-1903
        • Lossick J.C
        • Kent H.L
        Trichomoniasis: trends in diagnosis and management.
        Am J Obstet Gynecol. 1991; 165: 1217-1222
        • Schneider H
        • Coetzee D.J
        • Fehler H.G
        • Belligan A
        • Dangor Y
        • Radebe F
        • et al.
        Screening for sexually transmitted diseases in rural South African women.
        Sex Transm Dis. 1998; 74: S147-S152
        • Moodley P
        • Connolly C
        • Sturm W
        Interrelationships among HIV type 1 infection, bacterial vaginosis, trichomoniasis and the presence of yeasts.
        J Infect Dis. 2002; 185: 69-73
        • Thomason J.L
        • Gelbart S.M
        Trichomonas vaginalis.
        Obstet Gynecol. 1989; 74: 536-541
        • Ohlemeyer C.L
        • Hornberger L.L
        • Lynch D.A
        • Swierkosz E.M
        Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopy.
        J Adolesc Health. 1998; 22: 205-208
        • Krieger J.N
        • Verdon M
        • Siegel N
        • Holmes K.K
        Natural history of urogenital trichomoniasis in men.
        J Urol. 1993; 149: 1455-1458
      2. Xenostrip-Tv package insert.
        Xenotype Diagnostics, San Antonio (TX)2002
        • Lyng J
        • Christen J
        A double-blind study of the value of treatment with a single dose of tinidazole of partners to females with trichomoniasis.
        Acta Obstet Gynecol Scand. 1981; 60: 199-201
      3. 2002 Sexually transmitted diseases treatment guidelines.
        MMWR Morb Mortal Wkly Rep. 2002; 51: 44-45
        • Schmid G
        • Narcisi E
        • Mosure D
        • Secor E
        • Higgins J
        • Moreno H
        Prevalence of metronidazole resistant Trichomonas vaginalis in a gynecology clinic.
        J Reprod Med. 2001; 46: 545-549
        • Sobel J.D
        • Nagappan V
        • Nyirjesy P
        Metronidazole resistant vaginal trichomoniasis an emerging problem.
        N Engl J Med. 1999; 341: 292-293
        • Lossick J.G
        • Muller M
        • Gorrell T.E
        In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.
        J Infect Dis. 1986; 153: 948-955
        • Sobel J.D
        • Nyirjesy P
        • Brown W
        Tinidazole therapy for metronidazole resistant vaginal trichomoniasis.
        Clin Infect Dis. 2001; 33: 1341-1346
        • Sawyer P.R
        • Brogden R.N
        • Pinder R.M
        • Speight T.M
        • Avery G.S
        Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy.
        Drugs. 1976; 11: 423-440
        • Lossick J.G
        Therapy of urogenital trichominasis.
        in: Honigberg B.M Trichomonads parasitic in man. Springer Verlag, New York1989: 324-341
        • Hamed K.A
        • Studemeister A.E
        Successful response of metronidazole-resistant trichomonal vaginitis to tinidazole.
        Sex Transm Dis. 1992; 19: 339-340
        • Voolmann T
        • Borcham P
        Metronidazole resistant Trichomonas vaginalis in Brisbane.
        Med J Aust. 1993; 159: 490
        • Saurina G
        • DeMeo L
        • McCormack W.M
        Cure of metronidazole and tinidazole resistant trichominasis with use of high dose oral and intravaginal tinidazole.
        Clin Infect Dis. 1998; 26: 1238-1239
        • Dan M
        • Sobel J.D
        Trichomoniasis as seen in a chronic vaginitis clinic.
        Infect Dis Obstet Gynecol. 1996; 4: 77-84
        • Gillette H
        • Schmid G.P
        • Mosure D
        • Lossick J.G
        • Secor E
        • Narcisi L
        • et al.
        Metronidazole-resistant Trichomonas vaginalis, a case series, 1985-1998.
        ([abstract 067])Proceedings of the 13th meeting of the International Society of Sexually Transmitted Disease Research; 1999 July 11-14; Denver, Colo. The Society, Denver1999